Search
Polistes annularis venom protein
go.drugbank.com/drugs/DB11027ApprovedPolistes annularis venom protein is an extract of Polistes annularis venom. Polistes annularis venom protein is used in allergenic testing.
Categories: Bee and Wasp VenomGR270773
go.drugbank.com/drugs/DB06427InvestigationalGR270773, was investigated in two clinical trials for its potential to treat sepsis: NCT00158769 (completed, comparing the effects of infusion between healthy adults and those with damaged livers) and
DG041
go.drugbank.com/drugs/DB05027ExperimentalDG041, an anti-platelet compound, has shown to be a selective and potent antagonist of the EP3 receptor for prostaglandins E2. … It block the formation of blood clots mediated through inflammation in atherosclerotic plaques but without increasing bleeding risk.
Senna leaf
go.drugbank.com/drugs/DB15889ApprovedInvestigationalMixtures: SENNA LEAF and DOCUSATE SODIUMTC-2216
go.drugbank.com/drugs/DB06044InvestigationalTC-2216 is an investigational novel small molecule that is being developed as an oral treatment for depression and anxiety disorders. … TC-2216 showed greater potency than and anti-depressant effects comparable to selective serotonin reuptake inhibitors and tricyclics, which are commonly used treatments for depression, as well as anxiety-relieving
Pargyline
go.drugbank.com/drugs/DB01626ApprovedPargyline is a monoamine oxidase inhibitor with antihypertensive properties.
Categories: pargyline and diuretics, MAO Inhibitors and DiureticsFluorodopa (18F)
go.drugbank.com/drugs/DB13848ApprovedInvestigational[L12849] Fluorodopa F 18 PET is used adjunctly with other diagnostic investigations and serves primarily to visualize dopaminergic nerve terminals in the striatum.[L12849]
Categories: Amino Acids, Peptides, and ProteinsAGT-182
go.drugbank.com/drugs/DB17630InvestigationalAGT-182 is an investigational enzyme replacement therapy engineered by the fusion of the iduronate-2-sulfatase (IDS) enzyme and a human insulin receptor monoclonal antibody.
AVR118
go.drugbank.com/drugs/DB04979Investigationalof cancers); for its ability to stimulate the immune system to attack tumor cells (especially those cancer cells that have been damaged by chemotherapeutic agents) and for its ability to treat cachexia … papilloma virus and to dampen aberrant autoimmune-type inflammatory responses.
Categories: Nucleic Acids, Nucleotides, and NucleosidesAX200
go.drugbank.com/drugs/DB05093Investigationalthrough the induction of neuro- and arteriogenesis and supporting the reorganisation of the nervous system. … AX200, which has been developed for the treatment of stroke, is the most advanced drug candidate and is halfway through the process of gaining clinical approval.